Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 34

1.

Subcellular compartmentalization of PKM2 identifies anti-PKM2 therapy response in vitro and in vivo mouse model of human non-small-cell lung cancer.

Suzuki A, Puri S, Leland P, Puri A, Moudgil T, Fox BA, Puri RK, Joshi BH.

PLoS One. 2019 May 23;14(5):e0217131. doi: 10.1371/journal.pone.0217131. eCollection 2019.

2.

Future Research Goals in Immunotherapy.

Hulett TW, Fox BA, Messenheimer DJ, Marwitz S, Moudgil T, Afentoulis ME, Wegman KW, Ballesteros-Merino C, Jensen SM.

Surg Oncol Clin N Am. 2019 Jul;28(3):505-518. doi: 10.1016/j.soc.2019.02.006. Epub 2019 Apr 12. Review.

PMID:
31079803
3.

Co-expression of CD39 and CD103 identifies tumor-reactive CD8 T cells in human solid tumors.

Duhen T, Duhen R, Montler R, Moses J, Moudgil T, de Miranda NF, Goodall CP, Blair TC, Fox BA, McDermott JE, Chang SC, Grunkemeier G, Leidner R, Bell RB, Weinberg AD.

Nat Commun. 2018 Jul 13;9(1):2724. doi: 10.1038/s41467-018-05072-0.

4.

A pilot study of an autologous tumor-derived autophagosome vaccine with docetaxel in patients with stage IV non-small cell lung cancer.

Sanborn RE, Ross HJ, Aung S, Acheson A, Moudgil T, Puri S, Hilton T, Fisher B, Coffey T, Paustian C, Neuberger M, Walker E, Hu HM, Urba WJ, Fox BA.

J Immunother Cancer. 2017 Dec 19;5(1):103. doi: 10.1186/s40425-017-0306-6.

5.

Ubiquitinated Proteins Isolated From Tumor Cells Are Efficient Substrates for Antigen Cross-Presentation.

Yu G, Moudgil T, Cui Z, Mou Y, Wang L, Fox BA, Hu HM.

J Immunother. 2017 Jun;40(5):155-163. doi: 10.1097/CJI.0000000000000165.

PMID:
28368960
6.

Multispectral imaging of formalin-fixed tissue predicts ability to generate tumor-infiltrating lymphocytes from melanoma.

Feng Z, Puri S, Moudgil T, Wood W, Hoyt CC, Wang C, Urba WJ, Curti BD, Bifulco CB, Fox BA.

J Immunother Cancer. 2015 Oct 20;3:47. doi: 10.1186/s40425-015-0091-z. eCollection 2015.

7.

Cross-presentation of viral antigens in dribbles leads to efficient activation of virus-specific human memory T cells.

Ye W, Xing Y, Paustian C, van de Ven R, Moudgil T, Hilton TL, Fox BA, Urba WJ, Zhao W, Hu HM.

J Transl Med. 2014 Apr 16;12:100. doi: 10.1186/1479-5876-12-100.

8.

OX40 is a potent immune-stimulating target in late-stage cancer patients.

Curti BD, Kovacsovics-Bankowski M, Morris N, Walker E, Chisholm L, Floyd K, Walker J, Gonzalez I, Meeuwsen T, Fox BA, Moudgil T, Miller W, Haley D, Coffey T, Fisher B, Delanty-Miller L, Rymarchyk N, Kelly T, Crocenzi T, Bernstein E, Sanborn R, Urba WJ, Weinberg AD.

Cancer Res. 2013 Dec 15;73(24):7189-7198. doi: 10.1158/0008-5472.CAN-12-4174. Epub 2013 Oct 31.

9.

Signaling through OX40 enhances antitumor immunity.

Jensen SM, Maston LD, Gough MJ, Ruby CE, Redmond WL, Crittenden M, Li Y, Puri S, Poehlein CH, Morris N, Kovacsovics-Bankowski M, Moudgil T, Twitty C, Walker EB, Hu HM, Urba WJ, Weinberg AD, Curti B, Fox BA.

Semin Oncol. 2010 Oct;37(5):524-32. doi: 10.1053/j.seminoncol.2010.09.013. Review.

10.

Cancer immunotherapy: the role regulatory T cells play and what can be done to overcome their inhibitory effects.

Petrausch U, Poehlein CH, Jensen SM, Twitty C, Thompson JA, Assmann I, Puri S, LaCelle MG, Moudgil T, Maston L, Friedman K, Church S, Cardenas E, Haley DP, Walker EB, Akporiaye E, Weinberg AD, Rosenheim S, Crocenzi TS, Hu HM, Curti BD, Urba WJ, Fox BA.

Curr Mol Med. 2009 Aug;9(6):673-82. Review.

11.

Characterization of immune responses in gastric cancer patients: a possible impact of H. pylori to polarize a tumor-specific type 1 response?

van den Engel NK, Winter H, Rüttinger D, Shau I, Schiller M, Mayer B, Moudgil T, Meimarakis G, Stolte M, Jauch KW, Fox BA, Hatz RA.

Clin Immunol. 2006 Sep;120(3):285-96. Epub 2006 Jun 9.

PMID:
16765089
12.
13.

Manipulating the host response to autologous tumour vaccines.

Ma J, Poehlein CH, Jensen SM, LaCelle MG, Moudgil TM, Rüttinger D, Haley D, Goldstein MJ, Smith JW 3rd, Curti B, Ross H, Walker E, Hu HM, Urba WJ, Fox BA.

Dev Biol (Basel). 2004;116:93-107; discussion 133-43.

PMID:
15603186
14.

Vaccination of women with metastatic breast cancer, using a costimulatory gene (CD80)-modified, HLA-A2-matched, allogeneic, breast cancer cell line: clinical and immunological results.

Dols A, Smith JW 2nd, Meijer SL, Fox BA, Hu HM, Walker E, Rosenheim S, Moudgil T, Doran T, Wood W, Seligman M, Alvord WG, Schoof D, Urba WJ.

Hum Gene Ther. 2003 Jul 20;14(11):1117-23.

PMID:
12885350
15.

Immunological and molecular analysis of the sentinel lymph node: a potential approach to predict outcome, tailor therapy, and optimize parameters for tumor vaccine development.

Meijer SL, Dols A, Hu HM, Jensen S, Poehlein CH, Chu Y, Winter H, Yamada J, Moudgil T, Wood WJ, Doran T, Justice L, Fisher B, Wisner P, Wood J, Vetto JT, Mehrotra R, Rosenheim S, Weinberg AD, Bright R, Walker E, Puri R, Smith JW 2nd, Urba WJ, Fox BA.

J Clin Pharmacol. 2001 Jul;41(S7):81S-94S. Review. No abstract available.

PMID:
11452734
16.
17.

Coreceptor utilization by human immunodeficiency virus type 1 is not a primary determinant of neutralization sensitivity.

LaCasse RA, Follis KE, Moudgil T, Trahey M, Binley JM, Planelles V, Zolla-Pazner S, Nunberg JH.

J Virol. 1998 Mar;72(3):2491-5.

18.

Mycosis fungoides and Sezary syndrome are not associated with HTLV-I infection: an international study.

Bazarbachi A, Soriano V, Pawson R, Vallejo A, Moudgil T, Matutes E, Peries J, Molina A, de The H, Schulz TF, Catovsky D, Gill PS.

Br J Haematol. 1997 Sep;98(4):927-33.

PMID:
9326191
19.

Interleukin-10 is an autocrine growth factor for acquired immunodeficiency syndrome-related B-cell lymphoma.

Masood R, Zhang Y, Bond MW, Scadden DT, Moudgil T, Law RE, Kaplan MH, Jung B, Espina BM, Lunardi-Iskandar Y, et al.

Blood. 1995 Jun 15;85(12):3423-30.

PMID:
7780129
20.

IL-10 inhibits HIV-1 replication and is induced by tat.

Masood R, Lunardi-Iskandar Y, Moudgil T, Zhang Y, Law RE, Huang CL, Puri RK, Levine AM, Gill PS.

Biochem Biophys Res Commun. 1994 Jul 15;202(1):374-83.

PMID:
8037735
21.

Human T-cell lymphotropic virus type I-associated retinal lymphoma. A clinicopathologic report.

Kumar SR, Gill PS, Wagner DG, Dugel PU, Moudgil T, Rao NA.

Arch Ophthalmol. 1994 Jul;112(7):954-9.

PMID:
8031276
22.

All-trans retinoic acid for the treatment of AIDS-related Kaposi's sarcoma: results of a pilot phase II study.

Gill PS, Espina BM, Moudgil T, Kidane S, Esplin JA, Tulpule A, Levine AM.

Leukemia. 1994;8 Suppl 3:S26-32.

PMID:
7808021
23.

Infectious decay of human immunodeficiency virus type 1 in plasma.

Moudgil T, Daar ES.

J Infect Dis. 1993 Jan;167(1):210-2.

PMID:
8418169
24.

Rapid generation of sequence variation during primary HIV-1 infection.

Pang S, Shlesinger Y, Daar ES, Moudgil T, Ho DD, Chen IS.

AIDS. 1992 May;6(5):453-60. Erratum in: AIDS 1992 Jun;6(6):following 606.

PMID:
1616650
25.

Transient high levels of viremia in patients with primary human immunodeficiency virus type 1 infection.

Daar ES, Moudgil T, Meyer RD, Ho DD.

N Engl J Med. 1991 Apr 4;324(14):961-4.

26.
27.

Seroprevalence of human T cell leukemia viruses in selected populations of homosexual men.

Meyer RD, Moudgil T, Detels R, Phair JP, Hirsch MS, Ho DD.

J Infect Dis. 1990 Dec;162(6):1370-2.

PMID:
2230268
28.

HIV-2 in Los Angeles.

Ho DD, Lee S, Moudgil T, Kerndt PR.

AIDS. 1990 Dec;4(12):1301-2. No abstract available.

PMID:
1982414
29.
30.

CD4-independent, productive human immunodeficiency virus type 1 infection of hepatoma cell lines in vitro.

Cao YZ, Friedman-Kien AE, Huang YX, Li XL, Mirabile M, Moudgil T, Zucker-Franklin D, Ho DD.

J Virol. 1990 Jun;64(6):2553-9.

31.
32.

Quantitation of human immunodeficiency virus type 1 in the blood of infected persons.

Ho DD, Moudgil T, Alam M.

N Engl J Med. 1989 Dec 14;321(24):1621-5.

PMID:
2586564
33.

HIV-1, HIV-2, and HTLV-I infection in high-risk groups in Brazil.

Cortes E, Detels R, Aboulafia D, Li XL, Moudgil T, Alam M, Bonecker C, Gonzaga A, Oyafuso L, Tondo M.

N Engl J Med. 1989 Apr 13;320(15):953-8.

PMID:
2927478
34.

Human immunodeficiency virus type 1 in a seronegative patient with visceral Kaposi's sarcoma and hypogammaglobulinemia.

Ho DD, Moudgil T, Robin HS, Alam M, Wallace BJ, Mizrachi Y.

Am J Med. 1989 Mar;86(3):349-51. No abstract available.

PMID:
2919620

Supplemental Content

Loading ...
Support Center